These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 25430863)

  • 61. Design, synthesis and cytotoxic effect of hydroxy- and 3-alkylaminopropoxy-9,10-anthraquinone derivatives.
    Teng CH; Won SJ; Lin CN
    Bioorg Med Chem; 2005 May; 13(10):3439-45. PubMed ID: 15848756
    [TBL] [Abstract][Full Text] [Related]  

  • 62. SAR and biological evaluation of analogues of a small molecule histone deacetylase inhibitor N-(2-aminophenyl)-4-((4-(pyridin-3-yl)pyrimidin-2-ylamino)methyl)benzamide (MGCD0103).
    Raeppel S; Zhou N; Gaudette F; Leit S; Paquin I; Larouche G; Moradei O; Fréchette S; Isakovic L; Delorme D; Fournel M; Kalita A; Lu A; Trachy-Bourget MC; Yan PT; Liu J; Rahil J; Wang J; Besterman JM; Murakami K; Li Z; Vaisburg A
    Bioorg Med Chem Lett; 2009 Feb; 19(3):644-9. PubMed ID: 19114304
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Growth inhibition of human hepatoma cells by acyclic retinoid is associated with induction of p21(CIP1) and inhibition of expression of cyclin D1.
    Suzui M; Masuda M; Lim JT; Albanese C; Pestell RG; Weinstein IB
    Cancer Res; 2002 Jul; 62(14):3997-4006. PubMed ID: 12124333
    [TBL] [Abstract][Full Text] [Related]  

  • 64. 3,5-Dimethyl-H-furo[3,2-g]chromen-7-one as a potential anticancer drug by inducing p53-dependent apoptosis in human hepatoma HepG2 cells.
    Sun JG; Chen CY; Luo KW; Yeung CL; Tsang TY; Huang ZZ; Wu P; Fung KP; Kwok TT; Liu FY
    Chemotherapy; 2011; 57(2):162-72. PubMed ID: 21454974
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Emodin-induced apoptosis through p53-dependent pathway in human hepatoma cells.
    Shieh DE; Chen YY; Yen MH; Chiang LC; Lin CC
    Life Sci; 2004 Mar; 74(18):2279-90. PubMed ID: 14987952
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Effect of Oxaliplatin on cell cycle of hepatocellular carcinoma cell line HepG2].
    Gao J; Wang R; Yang Q; Chen C; Wu Q
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2013 Jul; 42(4):437-42. PubMed ID: 24022933
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Novel rotundic acid derivatives: synthesis, structural characterization and in vitro antitumor activity.
    Chen Y; He YF; Nan ML; Sun WY; Hu J; Cui A; Li F; Wang F
    Int J Mol Med; 2013 Feb; 31(2):353-60. PubMed ID: 23233042
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
    Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
    Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Identification of a 3,3-difluorinated tetrahydropyridinol compound as a novel antitumor agent for hepatocellular carcinoma acting via cell cycle arrest through disturbing CDK7-mediated phosphorylation of Cdc2.
    Bi W; Xiao JC; Liu RJ; Zhou LY; Zhang S; Yang M; Zhang PF
    Invest New Drugs; 2020 Apr; 38(2):287-298. PubMed ID: 31076964
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A rational design strategy of the novel topoisomerase II inhibitors for the synthesis of the 4-O-(2-pyrazinecarboxylic)-4'-demethylepipodophyllotoxin with antitumor activity by diminishing the relaxation reaction of topoisomerase II-DNA decatenation.
    Zhao W; Chen L; Li HM; Wang DJ; Li DS; Chen T; Yuan ZP; Tang YJ
    Bioorg Med Chem; 2014 Jun; 22(11):2998-3007. PubMed ID: 24775914
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Ethyl pyruvate inhibits proliferation and induces apoptosis of hepatocellular carcinoma via regulation of the HMGB1-RAGE and AKT pathways.
    Cheng P; Dai W; Wang F; Lu J; Shen M; Chen K; Li J; Zhang Y; Wang C; Yang J; Zhu R; Zhang H; Zheng Y; Guo CY; Xu L
    Biochem Biophys Res Commun; 2014 Jan; 443(4):1162-8. PubMed ID: 24361892
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Design, Synthesis and Evaluation of Naphthalimide Derivatives as Potential Anticancer Agents for Hepatocellular Carcinoma.
    Ge C; Chang L; Zhao Y; Chang C; Xu X; He H; Wang Y; Dai F; Xie S; Wang C
    Molecules; 2017 Feb; 22(2):. PubMed ID: 28241441
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cell cycle and apoptosis alteration of human hepatocarcinoma cells by subclinical-dose 12C6+-beam irradiation.
    Liu B; Zhang H; Xie Y; Hao J; Duan X; Zhou Q; Qiu R; Zhou G
    Eur J Gastroenterol Hepatol; 2007 Sep; 19(9):749-54. PubMed ID: 17700259
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Design, synthesis and biological evaluation of aloperine derivatives as potential anticancer agents.
    Zhao TT; Shen LY; Cheng Y; Liu XY; Chen K; Sun BM; Li Y; Pan XD
    J Asian Nat Prod Res; 2024 Sep; 26(9):1057-1086. PubMed ID: 38920368
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Anticancer activity of new cationic arylthiophenes against hepatocellular carcinoma.
    Al-Shun SA; El-Senduny FF; Ismail MA; El-Sayed WM; Badria FA; Youssef MM
    Life Sci; 2021 Mar; 269():119028. PubMed ID: 33444618
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Synthesis and biological evaluation of novel derivatives of gambogic acid as anti-hepatocellular carcinoma agents.
    He L; Ling Y; Fu L; Yin D; Wang X; Zhang Y
    Bioorg Med Chem Lett; 2012 Jan; 22(1):289-92. PubMed ID: 22153338
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Design, synthesis and biological evaluation of novel (E)-N-phenyl-4-(pyridine-acylhydrazone) benzamide derivatives as potential antitumor agents for the treatment of multiple myeloma (MM).
    Li XY; Li S; Lu GQ; Wang DP; Liu KL; Qian XH; Xue WH; Meng FH
    Bioorg Chem; 2020 Oct; 103():104189. PubMed ID: 32890996
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Design, synthesis and biological evaluation of novel 4-(pyrrolo[2,3-d]pyrimidine-4-yloxy)benzamide derivatives as potential antitumor agents.
    Zhang J; Xiong H; Yang F; He J; Chen T; Fu D; Zheng P; Tang Q
    Bioorg Med Chem Lett; 2021 Feb; 33():127740. PubMed ID: 33316412
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Anticancer pyridines induce G2/M arrest and apoptosis via p53 and JNK upregulation in liver and breast cancer cells.
    Androutsopoulos VP; Spandidos DA
    Oncol Rep; 2018 Feb; 39(2):519-524. PubMed ID: 29207138
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Design and synthesis of novel 4'-demethyl-4-deoxypodophyllotoxin derivatives as potential anticancer agents.
    Zhu X; Fu J; Tang Y; Gao Y; Zhang S; Guo Q
    Bioorg Med Chem Lett; 2016 Feb; 26(4):1360-4. PubMed ID: 26804229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.